Chlormezanone

This classification denotes an anxiolytic with the molecular formula C11H12ClNO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GP568V9G19, chemically known as 4h-1,3-thiazin-4-one, tetrahydro-2-(p-chlorophenyl)-3-methyl-, 1,1-dioxide but generally known as chlormezanone, which bears US NIH Compound Identifier 2717. European Medicines Agency schedules Chlormezanone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06187MIG. The term CHLORMEZANONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules chlormezanone in its Anatomical Therapeutic Chemical (ATC) Classification. CHLORMEZANONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule chlormezanone under HS 29349990 and SITC 51579. As of Q4 2014, CHLORMEZANONE remains the US FDA Preferred Term for this commodity. Chlormezanone bears US NLM identifiers UMLS ID C0008223 and NCI Concept Code C65316. SMILES: CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)CL.